Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and vialinin a

acetylleucyl-leucyl-norleucinal has been researched along with vialinin a in 1 studies

Compound Research Comparison

Studies
(acetylleucyl-leucyl-norleucinal)
Trials
(acetylleucyl-leucyl-norleucinal)
Recent Studies (post-2010)
(acetylleucyl-leucyl-norleucinal)
Studies
(vialinin a)
Trials
(vialinin a)
Recent Studies (post-2010) (vialinin a)
32105319014

Protein Interaction Comparison

ProteinTaxonomyacetylleucyl-leucyl-norleucinal (IC50)vialinin a (IC50)
Ubiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)5.9
Ubiquitin carboxyl-terminal hydrolase 4Homo sapiens (human)1.5
Sentrin-specific protease 1Homo sapiens (human)1.765

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, N; Akiyama, T; Koshino, H; Okada, K; Onose, J; Takahashi, S; Taniguchi, K; Yajima, A; Yajima, S; Ye, YQ; Yoshida, A; Yoshioka, Y1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and vialinin a

ArticleYear
Vialinin A is a ubiquitin-specific peptidase inhibitor.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Endopeptidases; Protease Inhibitors; Protein Binding; Rats; Recombinant Proteins; Terphenyl Compounds

2013